A 52-year-old man with non-alcoholic fatty liver disease (NAFLD) confirmed on ultrasound and elevated ALT has no evidence of cirrhosis. He has BMI 33 kg/m², type 2 diabetes and hyperlipidaemia. What is the most important disease-modifying intervention to reduce his liver-related risk?